Emerging infectious agents
Identifieur interne : 004E32 ( Main/Exploration ); précédent : 004E31; suivant : 004E33Emerging infectious agents
Auteurs : D. A. Leiby [États-Unis]Source :
- Developments in biologicals [ 1424-6074 ] ; 2005.
Descripteurs français
- KwdFr :
- Adaptation physiologique, Animaux, Comportement, Environnement, Humains, Maladies transmises par les tiques (épidémiologie), Maladies transmissibles émergentes, Santé publique, Virus du Nil occidental (pathogénicité), Virus du Nil occidental (physiologie), Virus du SRAS (pathogénicité), Virus du SRAS (physiologie).
- MESH :
- pathogénicité : Virus du Nil occidental, Virus du SRAS.
- physiologie : Virus du Nil occidental, Virus du SRAS.
- épidémiologie : Maladies transmises par les tiques.
- Pascal (Inist)
- Adaptation physiologique, Animaux, Comportement, Environnement, Humains, Maladies transmissibles émergentes, Santé publique, Trypanosoma cruzi, Virus West Nile, Babesia microti, Homme, Syndrome respiratoire aigu sévère, Receveur, Sang, Transfusion, Sécurité transfusionnelle, Adaptation, Transmission, Toxicité, Maladie émergente.
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adaptation, Adaptation, Physiological, Animals, Babesia microti, Behavior, Blood, Communicable Diseases, Emerging, Emerging disease, Environment, Human, Humans, Public Health, Recipient, SARS Virus (pathogenicity), SARS Virus (physiology), Severe acute respiratory syndrome, Tick-Borne Diseases (epidemiology), Toxicity, Transfusion, Transfusion safety, Transmission, Trypanosoma cruzi, West Nile virus, West Nile virus (pathogenicity), West Nile virus (physiology).
- MESH :
- epidemiology : Tick-Borne Diseases.
- pathogenicity : SARS Virus, West Nile virus.
- physiology : SARS Virus, West Nile virus.
- Adaptation, Physiological, Animals, Behavior, Communicable Diseases, Emerging, Environment, Humans, Public Health.
Abstract
As new agents of infectious disease continue to emerge and old antagonists re-emerge, it is clear that the war on infectious disease is far from over. Indeed, the appearance of SARS during the past year is the latest example of the continuing challenges posed by agents of infectious disease. Emerging agents are threats not only to the general population, but also to recipients of blood transfusions. Today a variety of emerging agents are of concern to transfusion safety including Trypanosoma cruzi, West Nile virus, and Babesia microti to name but a few. These and other emerging agents have arisen or have been introduced partly through changes in donor demographics, international travel, microbial adaptations, land use, and human behaviour. Unfortunately, for many of these agents there is an absence of viable tests or other sound interventions to prevent their transmission at this time.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000625
- to stream PascalFrancis, to step Curation: 000365
- to stream PascalFrancis, to step Checkpoint: 000658
- to stream Main, to step Merge: 005178
- to stream PubMed, to step Corpus: 002616
- to stream PubMed, to step Curation: 002616
- to stream PubMed, to step Checkpoint: 002731
- to stream Ncbi, to step Merge: 001086
- to stream Ncbi, to step Curation: 001086
- to stream Ncbi, to step Checkpoint: 001086
- to stream Main, to step Merge: 004B48
- to stream Main, to step Curation: 004E32
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Emerging infectious agents</title><author><name sortKey="Leiby, D A" sort="Leiby, D A" uniqKey="Leiby D" first="D. A." last="Leiby">D. A. Leiby</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Transmissible Diseases Department, Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross</s1><s2>Rockville, MD</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Maryland</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0368719</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0368719 INIST</idno><idno type="RBID">Pascal:05-0368719</idno><idno type="wicri:Area/PascalFrancis/Corpus">000625</idno><idno type="wicri:Area/PascalFrancis/Curation">000365</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000658</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000658</idno><idno type="wicri:doubleKey">1424-6074:2005:Leiby D:emerging:infectious:agents</idno><idno type="wicri:Area/Main/Merge">005178</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16050150</idno><idno type="wicri:Area/PubMed/Corpus">002616</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002616</idno><idno type="wicri:Area/PubMed/Curation">002616</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002616</idno><idno type="wicri:Area/PubMed/Checkpoint">002731</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002731</idno><idno type="wicri:Area/Ncbi/Merge">001086</idno><idno type="wicri:Area/Ncbi/Curation">001086</idno><idno type="wicri:Area/Ncbi/Checkpoint">001086</idno><idno type="wicri:doubleKey">1424-6074:2005:Leiby D:emerging:infectious:agents</idno><idno type="wicri:Area/Main/Merge">004B48</idno><idno type="wicri:Area/Main/Curation">004E32</idno><idno type="wicri:Area/Main/Exploration">004E32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Emerging infectious agents</title><author><name sortKey="Leiby, D A" sort="Leiby, D A" uniqKey="Leiby D" first="D. A." last="Leiby">D. A. Leiby</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Transmissible Diseases Department, Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross</s1><s2>Rockville, MD</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Developments in biologicals</title><title level="j" type="abbreviated">Dev. biol.</title><idno type="ISSN">1424-6074</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Developments in biologicals</title><title level="j" type="abbreviated">Dev. biol.</title><idno type="ISSN">1424-6074</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptation</term><term>Adaptation, Physiological</term><term>Animals</term><term>Babesia microti</term><term>Behavior</term><term>Blood</term><term>Communicable Diseases, Emerging</term><term>Emerging disease</term><term>Environment</term><term>Human</term><term>Humans</term><term>Public Health</term><term>Recipient</term><term>SARS Virus (pathogenicity)</term><term>SARS Virus (physiology)</term><term>Severe acute respiratory syndrome</term><term>Tick-Borne Diseases (epidemiology)</term><term>Toxicity</term><term>Transfusion</term><term>Transfusion safety</term><term>Transmission</term><term>Trypanosoma cruzi</term><term>West Nile virus</term><term>West Nile virus (pathogenicity)</term><term>West Nile virus (physiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adaptation physiologique</term><term>Animaux</term><term>Comportement</term><term>Environnement</term><term>Humains</term><term>Maladies transmises par les tiques (épidémiologie)</term><term>Maladies transmissibles émergentes</term><term>Santé publique</term><term>Virus du Nil occidental (pathogénicité)</term><term>Virus du Nil occidental (physiologie)</term><term>Virus du SRAS (pathogénicité)</term><term>Virus du SRAS (physiologie)</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Tick-Borne Diseases</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term><term>West Nile virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du Nil occidental</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du Nil occidental</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term><term>West Nile virus</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmises par les tiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adaptation, Physiological</term><term>Animals</term><term>Behavior</term><term>Communicable Diseases, Emerging</term><term>Environment</term><term>Humans</term><term>Public Health</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adaptation physiologique</term><term>Animaux</term><term>Comportement</term><term>Environnement</term><term>Humains</term><term>Maladies transmissibles émergentes</term><term>Santé publique</term><term>Trypanosoma cruzi</term><term>Virus West Nile</term><term>Babesia microti</term><term>Homme</term><term>Syndrome respiratoire aigu sévère</term><term>Receveur</term><term>Sang</term><term>Transfusion</term><term>Sécurité transfusionnelle</term><term>Adaptation</term><term>Transmission</term><term>Toxicité</term><term>Maladie émergente</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As new agents of infectious disease continue to emerge and old antagonists re-emerge, it is clear that the war on infectious disease is far from over. Indeed, the appearance of SARS during the past year is the latest example of the continuing challenges posed by agents of infectious disease. Emerging agents are threats not only to the general population, but also to recipients of blood transfusions. Today a variety of emerging agents are of concern to transfusion safety including Trypanosoma cruzi, West Nile virus, and Babesia microti to name but a few. These and other emerging agents have arisen or have been introduced partly through changes in donor demographics, international travel, microbial adaptations, land use, and human behaviour. Unfortunately, for many of these agents there is an absence of viable tests or other sound interventions to prevent their transmission at this time.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Leiby, D A" sort="Leiby, D A" uniqKey="Leiby D" first="D. A." last="Leiby">D. A. Leiby</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:05-0368719
|texte= Emerging infectious agents
}}
| This area was generated with Dilib version V0.6.33. |  |